Araújo A - Search Results

1

Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal.

Araújo A, Tavares N, Faria AL, Gomes R, Mendonça JC, Parente B, Capela A, Barata F, Macedo A. Araújo A, et al. Curr Oncol. 2023 Jan 24;30(2):1529-1537. doi: 10.3390/curroncol30020117. Curr Oncol. 2023. PMID: 36826078 Free PMC article.

2

Health outcomes and budget impact projection of anti-PD-(L)1s in cancer care in Portugal.

Costa L, Alexandre T, Mansinho A, Sousa R, Vieira C, Hughes R, Roediger A, Pereira SM, Araújo A. Costa L, et al. Among authors: araujo a. Front Public Health. 2023 May 12;11:1133959. doi: 10.3389/fpubh.2023.1133959. eCollection 2023. Front Public Health. 2023. PMID: 37250095 Free PMC article.

3

Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center.

Coelho JQ, Romão R, Sousa MJ, Azevedo SX, Fidalgo P, Araújo A. Coelho JQ, et al. Among authors: araujo a. Curr Oncol. 2024 Feb 19;31(2):1113-1128. doi: 10.3390/curroncol31020083. Curr Oncol. 2024. PMID: 38392077 Free PMC article.

4

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.

Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, Castro G Jr, Srimuninnimit V, Laktionov KK, Bondarenko I, Kubota K, Lubiniecki GM, Zhang J, Kush D, Lopes G; KEYNOTE-042 Investigators. Mok TSK, et al. Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4. Lancet. 2019. PMID: 30955977 Clinical Trial.

5

The Effect of Timeliness of Care on Lung Cancer Survival - A Population-Based Approach.

Guerreiro T, Mayer A, Aguiar P, Araújo A, Nunes C. Guerreiro T, et al. Among authors: araujo a. Ann Glob Health. 2023 Jun 5;89(1):39. doi: 10.5334/aogh.3845. eCollection 2023. Ann Glob Health. 2023. PMID: 37304941 Free PMC article.

6

Chronic pain, functionality and quality of life in cancer survivors.

Poço Gonçalves J, Veiga D, Araújo A. Poço Gonçalves J, et al. Among authors: araujo a. Br J Pain. 2021 Nov;15(4):401-410. doi: 10.1177/2049463720972730. Epub 2020 Nov 30. Br J Pain. 2021. PMID: 34840788 Free PMC article.

7

Best Supportive Care of the Patient with Oesophageal Cancer.

Pichel RC, Araújo A, Domingues VDS, Santos JN, Freire E, Mendes AS, Romão R, Araújo A. Pichel RC, et al. Among authors: araujo a. Cancers (Basel). 2022 Dec 19;14(24):6268. doi: 10.3390/cancers14246268. Cancers (Basel). 2022. PMID: 36551753 Free PMC article. Review.

8

Impact of Immune-Related Adverse Events on Immune Checkpoint Inhibitors Treated Cancer Patients' Survival: Single Center Experience and Literature Review.

Romão R, Mendes AS, Ranchor R, Ramos MJ, Coelho J, Pichel RC, Azevedo SX, Fidalgo P, Araújo A. Romão R, et al. Among authors: araujo a. Cancers (Basel). 2023 Jan 31;15(3):888. doi: 10.3390/cancers15030888. Cancers (Basel). 2023. PMID: 36765845 Free PMC article.

9

Immunotherapy in Elderly Patients-Single-Center Experience.

Ramos MJ, Mendes AS, Romão R, Febra J, Araújo A. Ramos MJ, et al. Among authors: araujo a. Cancers (Basel). 2023 Dec 27;16(1):145. doi: 10.3390/cancers16010145. Cancers (Basel). 2023. PMID: 38201572 Free PMC article.

10

Prognostic value of microRNA-203a expression in breast cancer.

Gomes BC, Martins M, Lopes P, Morujão I, Oliveira M, Araújo A, Rueff J, Rodrigues AS. Gomes BC, et al. Among authors: araujo a. Oncol Rep. 2016 Sep;36(3):1748-56. doi: 10.3892/or.2016.4913. Epub 2016 Jul 5. Oncol Rep. 2016. PMID: 27431784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,966 results

Search Page